Moors & Cabot Inc. Sells 1,087 Shares of Colgate-Palmolive (NYSE:CL)

Moors & Cabot Inc. lowered its position in shares of Colgate-Palmolive (NYSE:CL) by 2.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 45,435 shares of the company’s stock after selling 1,087 shares during the period. Moors & Cabot Inc.’s holdings in Colgate-Palmolive were worth $4,717,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. EagleClaw Capital Managment LLC increased its stake in shares of Colgate-Palmolive by 0.9% during the third quarter. EagleClaw Capital Managment LLC now owns 32,879 shares of the company’s stock valued at $3,413,000 after buying an additional 300 shares during the period. First Horizon Advisors Inc. increased its stake in shares of Colgate-Palmolive by 13.7% during the third quarter. First Horizon Advisors Inc. now owns 17,132 shares of the company’s stock valued at $1,779,000 after buying an additional 2,064 shares during the period. Advisors Asset Management Inc. increased its stake in shares of Colgate-Palmolive by 35.0% during the third quarter. Advisors Asset Management Inc. now owns 64,264 shares of the company’s stock valued at $6,671,000 after buying an additional 16,661 shares during the period. Connor Clark & Lunn Investment Management Ltd. increased its stake in shares of Colgate-Palmolive by 36.9% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 14,689 shares of the company’s stock valued at $1,525,000 after buying an additional 3,960 shares during the period. Finally, Commerce Bank grew its stake in Colgate-Palmolive by 0.3% in the third quarter. Commerce Bank now owns 145,487 shares of the company’s stock valued at $15,103,000 after purchasing an additional 425 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

NYSE CL traded down $0.44 during mid-day trading on Wednesday, hitting $93.17. The stock had a trading volume of 234,063 shares, compared to its average volume of 4,372,208. The firm’s 50 day moving average is $98.80 and its 200 day moving average is $98.56. Colgate-Palmolive has a twelve month low of $75.39 and a twelve month high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The stock has a market capitalization of $76.12 billion, a price-to-earnings ratio of 26.82, a PEG ratio of 3.34 and a beta of 0.42.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.15%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on CL shares. Redburn Atlantic upgraded Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. UBS Group boosted their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. Jefferies Financial Group downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their target price for the stock from $103.00 to $95.00 in a report on Wednesday, July 24th. TD Cowen decreased their target price on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a report on Monday, October 28th. Finally, JPMorgan Chase & Co. lifted their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and an average target price of $105.11.

Insider Activity at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This trade represents a 16.44 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.37% of the stock is owned by corporate insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.